[1]
Angelov, K. et al. 2026. Integration of genomic features, immunotherapy and targeted agents in the treatment of gallbladder and bile duct cancer – a review. Acta Medica Bulgarica. 53, Suppl 1 (Feb. 2026), 200–205. DOI:https://doi.org/10.2478/AMB-2026-0031.